Protagonist Therapeutics (PTGX) Amortizatization of Intangibles (2016 - 2026)

Protagonist Therapeutics (PTGX) has 11 years of Amortizatization of Intangibles data on file, last reported at $1.0 million in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles fell 55.22% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $6.0 million (down 37.6% YoY), and the FY2025 full-year result was $7.2 million, down 18.61% from the prior year.
• Amortizatization of Intangibles retreated to $1.0 million in Q1 2026, from $1.3 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $2.8 million in Q3 2024 to a low of -$358000.0 in Q1 2022.
• A 5-year average of $1.3 million and a median of $1.3 million in 2025 frame the typical range for Amortizatization of Intangibles.
• Across the five-year window, Amortizatization of Intangibles soared 1100.0% in 2023 and sank 55.22% in 2026, its largest moves.
• Tracing PTGX's Amortizatization of Intangibles over 5 years: stood at $914000.0 in 2022, then jumped by 47.48% to $1.3 million in 2023, then surged by 104.75% to $2.8 million in 2024, then tumbled by 51.59% to $1.3 million in 2025, then dropped by 23.28% to $1.0 million in 2026.
• Business Quant data shows PTGX's Amortizatization of Intangibles at $1.0 million in Q1 2026, $1.3 million in Q4 2025, and $1.7 million in Q3 2025.